|
|
Article: Number of Cancer Vaccine Players has Decreased through Operational Re-Prioritizations, M&As and Fall Outs.
- Article from:
- Business Wire
- Article date:
- September 15, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42155) has announced the addition of Analytical Tool - Competitive Outlook on Cancer Vaccines to their offering.
"Analytical Tool - Competitive Outlook on Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine R&D and business development. It is also a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The report also lays the framework of current treatment strategies and their progress. This tool provides you with an ...
Related newspaper, magazine, and journal articles:
|
|
Article: Cancer Vaccines Taniguchi, F.; Yamagishi, H.; ...
Gene Therapy Weekly;
January 11, 1999 ;
535 words
... ... therapeutic effect of TNF gene-transduced cancer vaccine and whether the vaccination effect ... murine model. TNF gene-transduced cancer vaccine or systemic administration of rIL ... therapy using TNF gene-transduced cancer vaccine and rIL-12." The corresponding ...
|
|